The hunt for the first-ever approved treatment for MOG Antibody Disease continues with another phase 3 clinical trial involving satralizumab. satralizumab will
Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease or MOG Antibody Disease (MOGAD) is a condition that causes inflammation to the optic nerve(s), brain,
A diagnosis of MOG Antibody Disease (MOGAD) can be overwhelming and trigger grief. Grief is a strong, often overwhelming emotion involving loss.
MOG Antibody Disease (MOGAD) relapses are one of a patient's biggest challenges. In this blog post, you will learn what a relapse
The first ever MOG Antibody Disease phase 3 clinical trial is now taking place. A new drug called Rozanolixizumab will be trialed
MOGAD support groups allow members to share experiences about their diagnosis, treatment, feelings, and other first-hand experiences. Healthcare providers treating patients with MOGAD